Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?

Similar findings to those of our study [1] suggesting that fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) is both insensitive and unspecific for evaluating indeterminate thyroid nodules have also been recently reported by Smith et al [2]. The argument of "s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of otolaryngology 2009-07, Vol.30 (4), p.292-293
Hauptverfasser: Hales, Nathan W., MD, Krempl, Greg A., MD, Medina, Jesus E., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 293
container_issue 4
container_start_page 292
container_title American journal of otolaryngology
container_volume 30
creator Hales, Nathan W., MD
Krempl, Greg A., MD
Medina, Jesus E., MD
description Similar findings to those of our study [1] suggesting that fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) is both insensitive and unspecific for evaluating indeterminate thyroid nodules have also been recently reported by Smith et al [2]. The argument of "size of the cancerous lesion" however does not completely explain the high false-negative results (eg, patient 1 had a negative FDG-PET/CT scan and a 1.4-cm solid papillary carcinoma).
doi_str_mv 10.1016/j.amjoto.2008.06.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1031357982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0196070908001245</els_id><sourcerecordid>2729896901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-a14fe836d680adffd8bed2e07c14cda663cb6b661eeebc19ee5dcd3bf68346d73</originalsourceid><addsrcrecordid>eNqVkd-K1TAQxosoeFx9Ay8CXrc7adqcnBtFFlcXFrxQwbuQJtOzqWmnJqnYJ_C1bTmC3no1w_DNv99XFC85VBy4vB4qMw6UqaoBVAWyAq4eFQfeirpUXH19XByAn2QJRzg9LZ6lNACAaER7KH7dJZYfMCIzLFJA1lNkfVgokkP6uZ7DYikhmyn5HGliOPqU_JZkGukczfywXlsa5yWj-6fG_MTsminQ2VsTwl5wmDGOfjIZt51rJO_YRG4JmN48L570JiR88SdeFV9u332--VDef3x_d_P2vrRCqFwa3vSohHRSgXF971SHrkY4Wt5YZ6QUtpOdlBwRO8tPiK2zTnS9VKKR7iiuileXuXOk7wumrAda4rSt1BwEF-3xpOpN1VxUNlJKEXs9Rz-auG4ivSPXg74g1ztyDVJvyLe215c23D744THqZD1OFp2PaLN25P93gA1-2gF-wxXT31N1qjXoT7uru6mgAHjdtOI3ZHGnNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031357982</pqid></control><display><type>article</type><title>Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hales, Nathan W., MD ; Krempl, Greg A., MD ; Medina, Jesus E., MD</creator><creatorcontrib>Hales, Nathan W., MD ; Krempl, Greg A., MD ; Medina, Jesus E., MD</creatorcontrib><description>Similar findings to those of our study [1] suggesting that fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) is both insensitive and unspecific for evaluating indeterminate thyroid nodules have also been recently reported by Smith et al [2]. The argument of "size of the cancerous lesion" however does not completely explain the high false-negative results (eg, patient 1 had a negative FDG-PET/CT scan and a 1.4-cm solid papillary carcinoma).</description><identifier>ISSN: 0196-0709</identifier><identifier>EISSN: 1532-818X</identifier><identifier>DOI: 10.1016/j.amjoto.2008.06.018</identifier><identifier>CODEN: AJOTDP</identifier><language>eng</language><publisher>Maryland Heights: Elsevier Inc</publisher><subject>Medical diagnosis ; Medical research ; Otolaryngology ; Surgery ; Thyroid gland ; Tomography ; Tumors</subject><ispartof>American journal of otolaryngology, 2009-07, Vol.30 (4), p.292-293</ispartof><rights>2009</rights><rights>Copyright Elsevier Limited 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c338t-a14fe836d680adffd8bed2e07c14cda663cb6b661eeebc19ee5dcd3bf68346d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0196070908001245$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Hales, Nathan W., MD</creatorcontrib><creatorcontrib>Krempl, Greg A., MD</creatorcontrib><creatorcontrib>Medina, Jesus E., MD</creatorcontrib><title>Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?</title><title>American journal of otolaryngology</title><description>Similar findings to those of our study [1] suggesting that fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) is both insensitive and unspecific for evaluating indeterminate thyroid nodules have also been recently reported by Smith et al [2]. The argument of "size of the cancerous lesion" however does not completely explain the high false-negative results (eg, patient 1 had a negative FDG-PET/CT scan and a 1.4-cm solid papillary carcinoma).</description><subject>Medical diagnosis</subject><subject>Medical research</subject><subject>Otolaryngology</subject><subject>Surgery</subject><subject>Thyroid gland</subject><subject>Tomography</subject><subject>Tumors</subject><issn>0196-0709</issn><issn>1532-818X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqVkd-K1TAQxosoeFx9Ay8CXrc7adqcnBtFFlcXFrxQwbuQJtOzqWmnJqnYJ_C1bTmC3no1w_DNv99XFC85VBy4vB4qMw6UqaoBVAWyAq4eFQfeirpUXH19XByAn2QJRzg9LZ6lNACAaER7KH7dJZYfMCIzLFJA1lNkfVgokkP6uZ7DYikhmyn5HGliOPqU_JZkGukczfywXlsa5yWj-6fG_MTsminQ2VsTwl5wmDGOfjIZt51rJO_YRG4JmN48L570JiR88SdeFV9u332--VDef3x_d_P2vrRCqFwa3vSohHRSgXF971SHrkY4Wt5YZ6QUtpOdlBwRO8tPiK2zTnS9VKKR7iiuileXuXOk7wumrAda4rSt1BwEF-3xpOpN1VxUNlJKEXs9Rz-auG4ivSPXg74g1ztyDVJvyLe215c23D744THqZD1OFp2PaLN25P93gA1-2gF-wxXT31N1qjXoT7uru6mgAHjdtOI3ZHGnNA</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Hales, Nathan W., MD</creator><creator>Krempl, Greg A., MD</creator><creator>Medina, Jesus E., MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20090701</creationdate><title>Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?</title><author>Hales, Nathan W., MD ; Krempl, Greg A., MD ; Medina, Jesus E., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-a14fe836d680adffd8bed2e07c14cda663cb6b661eeebc19ee5dcd3bf68346d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Medical diagnosis</topic><topic>Medical research</topic><topic>Otolaryngology</topic><topic>Surgery</topic><topic>Thyroid gland</topic><topic>Tomography</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hales, Nathan W., MD</creatorcontrib><creatorcontrib>Krempl, Greg A., MD</creatorcontrib><creatorcontrib>Medina, Jesus E., MD</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American journal of otolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hales, Nathan W., MD</au><au>Krempl, Greg A., MD</au><au>Medina, Jesus E., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?</atitle><jtitle>American journal of otolaryngology</jtitle><date>2009-07-01</date><risdate>2009</risdate><volume>30</volume><issue>4</issue><spage>292</spage><epage>293</epage><pages>292-293</pages><issn>0196-0709</issn><eissn>1532-818X</eissn><coden>AJOTDP</coden><abstract>Similar findings to those of our study [1] suggesting that fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) is both insensitive and unspecific for evaluating indeterminate thyroid nodules have also been recently reported by Smith et al [2]. The argument of "size of the cancerous lesion" however does not completely explain the high false-negative results (eg, patient 1 had a negative FDG-PET/CT scan and a 1.4-cm solid papillary carcinoma).</abstract><cop>Maryland Heights</cop><pub>Elsevier Inc</pub><doi>10.1016/j.amjoto.2008.06.018</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0196-0709
ispartof American journal of otolaryngology, 2009-07, Vol.30 (4), p.292-293
issn 0196-0709
1532-818X
language eng
recordid cdi_proquest_journals_1031357982
source ScienceDirect Journals (5 years ago - present)
subjects Medical diagnosis
Medical research
Otolaryngology
Surgery
Thyroid gland
Tomography
Tumors
title Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T19%3A42%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20there%20a%20role%20for%20fluorodeoxyglucose%20positron%20emission%20tomography/computed%20tomography%20in%20cytologically%20indeterminate%20thyroid%20nodules?&rft.jtitle=American%20journal%20of%20otolaryngology&rft.au=Hales,%20Nathan%20W.,%20MD&rft.date=2009-07-01&rft.volume=30&rft.issue=4&rft.spage=292&rft.epage=293&rft.pages=292-293&rft.issn=0196-0709&rft.eissn=1532-818X&rft.coden=AJOTDP&rft_id=info:doi/10.1016/j.amjoto.2008.06.018&rft_dat=%3Cproquest_cross%3E2729896901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1031357982&rft_id=info:pmid/&rft_els_id=1_s2_0_S0196070908001245&rfr_iscdi=true